Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-20-018373)

Filing Details

Accession Number:: 0001493152-20-018373
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-25 17:15:24
Reporting Period:: 2020-09-24

Accepted Time:: 2020-09-25 17:15:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Protara Therapeutics Inc.	"TARA"	Biological Products, (No Disgnostic Substances) (2836)	204580525

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595855	Opaleye Management Inc.	One Boston Place, 26Th Floor Boston MA 02108		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2020-09-24	100,000	$16.87	100,000	No	4	P	Indirect	By Managed Account
Common Stock, Par Value $0.001 Per Share	Acquisiton	2020-09-24	200,000	$16.87	2,408,472	No	4	P	Indirect	By Opaleye, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Managed Account
No	4	P	Indirect	By Opaleye, L.P.

Footnotes

Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.